During the past decade, CCBR Vejle conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCBR Vejle" #1 sponsor was "Kowa Research Europe" with 8 trials, followed by "Pfizer" with 5 trials sponsored, "Nordic Bioscience A/S" with 3 trials sponsored, "Biogen" with 2 trials sponsored and "Coloplast A/S" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Vejle" #1 collaborator was "Novartis" with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "CCBR Clinical Research" with 1 trials as a collaborator and "Larix A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CCBR Vejle" are "Dyslipidemia" (6 trials), "Hypercholesterolemia" (4 trials), "Alzheimer's Disease" (3 trials), "Osteoarthritis" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "CCBR Vejle" in a lesser frequency.

Most popular intervention types in "CCBR Vejle" are "Drug" (22 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Pitavastatin" (6 trials), "Atorvastatin" (3 trials), "Nicotine Replacement Therapy Patch" (2 trials) and "SMC021 Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "CCBR Vejle" are 23 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CCBR Vejle". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in CCBR Vejle, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CCBR Vejle, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".